Learn More
Medchemexpress LLC Eg00229 trifluoroacetate | 1210945-69-9 | 98.0% | 611.60 | C19H20F3N7O7S3 | 100 MG

Supplier: Medchemexpress LLC HY10799100MG
EG00229 trifluoroacetate is a small-molecule neuropilin-1 (NRP1) receptor antagonist supplied for research use. It selectively inhibits VEGF-A binding to the NRP1 b1 domain and is intended for in vitro and preclinical studies of NRP1-mediated signaling.
- Neuropilin-1 receptor antagonist that blocks VEGF-A binding.
- Reported IC50 ≈3 μM against purified NRP1 b1 domain and ≈8 μM in cell binding assays.
- Trifluoroacetate salt form for consistent formulation.
- High purity (≈98.0%).
- Molecular weight 611.6, suitable for biochemical and binding assays.
- Intended for research use in mechanistic and signaling studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.